DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Lofepramine

Lofepramine

  • Stopping Antidepressants

    Stopping Antidepressants

  • Lofepramine

    Lofepramine

  • Dose Equivalents of Antidepressants Evidence-Based Recommendations

    Dose Equivalents of Antidepressants Evidence-Based Recommendations

  • Cambridgeshire and Peterborough Joint Prescribing Group MEDICINE REVIEW

    Cambridgeshire and Peterborough Joint Prescribing Group MEDICINE REVIEW

  • Fatal Toxicity of Antidepressant Drugs in Overdose

    Fatal Toxicity of Antidepressant Drugs in Overdose

  • Association of Selective Serotonin Reuptake Inhibitors with the Risk for Spontaneous Intracranial Hemorrhage

    Association of Selective Serotonin Reuptake Inhibitors with the Risk for Spontaneous Intracranial Hemorrhage

  • Lofepramine Shortage – 21/12/2018

    Lofepramine Shortage – 21/12/2018

  • 3,2,4 Tricyclic Antidepressants and the Risk of Congenital Malformation

    3,2,4 Tricyclic Antidepressants and the Risk of Congenital Malformation

  • View Article

    View Article

  • Tricyclic Antidepressants Versus

    Tricyclic Antidepressants Versus

  • II.3.3 Tricyclic and Tetracyclic Antidepressants by Akira Namera and Mikio Yashiki

    II.3.3 Tricyclic and Tetracyclic Antidepressants by Akira Namera and Mikio Yashiki

  • Dosulepin (Prothiaden®): Guidance on Withdrawal

    Dosulepin (Prothiaden®): Guidance on Withdrawal

  • Primary Care BMJ: First Published As 10.1136/Bmj.323.7314.666 on 22 September 2001

    Primary Care BMJ: First Published As 10.1136/Bmj.323.7314.666 on 22 September 2001

  • Cost-Effectiveness of Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors and Lofepramine ISSN 1366-5278 Feedback Your Views About This Report

    Cost-Effectiveness of Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors and Lofepramine ISSN 1366-5278 Feedback Your Views About This Report

  • 1 Yorkshire Palliative Medicine Clinical Guidelines Group

    1 Yorkshire Palliative Medicine Clinical Guidelines Group

  • Which First-Line Antidepressant?

    Which First-Line Antidepressant?

  • Doxepin (Sinepin®): Guidance on Withdrawal

    Doxepin (Sinepin®): Guidance on Withdrawal

  • Trimipramine (Surmontil®): Guidance on Withdrawal

    Trimipramine (Surmontil®): Guidance on Withdrawal

Top View
  • Antidepressant” a Review of the Evidence for on and Off Label Uses
  • Lofepramine for Behaviour Problems
  • Hpft Guideline for Prescribing Tricyclic Antidepressants (Tca's) Key Reminders
  • BBBA9359 Lofepramine 70Mg 56 Tablets
  • Dosulepin FINAL.Pdf
  • PRODUCT INFORMATION Lofepramine Item No
  • Dosulepin (Prothiaden®): Guidance on Withdrawal
  • Trimipramine (Surmontil®): Guidance on Withdrawal
  • Prescribing Patterns of Antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) Study*
  • Tricyclics and Their Use in the Treatment of Pain and Insomnia
  • Formulary and Prescribing Guidelines
  • Esketamine for Treatment-Resistant Major Depressive Disorder
  • Summary of Product Characteristics
  • Depression Pathway Handy Hints When Prescribing Antidepressants
  • The Effectiveness of Depression Treatment for Adults with End-Stage Kidney Disease: a Systematic Review
  • DOSULEPIN DEPRESCRIBING Summary  Prescribers in Primary Care Should Not Initiate Dosulepin for Any New Patient
  • Combination of Morphinan Compounds and Antidepressant for the Treatment of Pseudobulbar Affect
  • Drug Therapy for Depression in Japan


© 2024 Docslib.org    Feedback